180 related articles for article (PubMed ID: 7681116)
1. Screening for occult nodal metastasis in localized carcinoma of the prostate.
Gomella LG; White JL; McCue PA; Byrne DS; Mulholland SG
J Urol; 1993 Apr; 149(4):776-8. PubMed ID: 7681116
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy.
Clobes H; Fossâ SD; Waehre H; Jocham D; Berner A
BJU Int; 2000 Feb; 85(3):270-5. PubMed ID: 10671880
[TBL] [Abstract][Full Text] [Related]
3. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
Potter SR; Mangold LA; Shue MJ; Taylor DC; Lecksell KL; Epstein JI; Walsh PC; Partin AW
Cancer; 2000 Dec; 89(12):2577-86. PubMed ID: 11135219
[TBL] [Abstract][Full Text] [Related]
4. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
6. Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
Kehr E; Masry P; Lis R; Loda M; Taplin ME; Hirsch MS
Histopathology; 2016 Jan; 68(2):303-7. PubMed ID: 26018610
[TBL] [Abstract][Full Text] [Related]
7. Screening for occult nodal metastasis in squamous cell carcinoma of the vulva.
Leys CM; Hartenbach EM; Hafez GR; Mahvi DM
Int J Gynecol Pathol; 2000 Jul; 19(3):243-7. PubMed ID: 10907173
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pathological study on nodal micrometastases of non-small-cell lung cancer].
Wang YX; Chu XY; Sun YE; Wang ZB; Li XH; Zhang GK
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(2):114-7. PubMed ID: 17418040
[TBL] [Abstract][Full Text] [Related]
9. The value of prostate-specific antigen levels in pelvic lymph nodes for diagnosing metastatic spread of prostate cancer.
Shoskes DA; Trachtenberg J
Can J Surg; 1993 Feb; 36(1):33-6. PubMed ID: 7680271
[TBL] [Abstract][Full Text] [Related]
10. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
11. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR.
Miyake H; Hara I; Kurahashi T; Inoue TA; Eto H; Fujisawa M
Clin Cancer Res; 2007 Feb; 13(4):1192-7. PubMed ID: 17317829
[TBL] [Abstract][Full Text] [Related]
12. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement.
Isebaert S; Haustermans K; Van den Bergh L; Joniau S; Dirix P; Oyen R; Deroose CM; Van Poppel H; Lerut E
Acta Oncol; 2013 Oct; 52(7):1336-44. PubMed ID: 23879650
[TBL] [Abstract][Full Text] [Related]
14. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
16. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor status of lymph node metastases from prostate cancer.
Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
Prostate; 1996 Feb; 28(2):129-35. PubMed ID: 8604394
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer.
van den Ouden D; Davidson PJ; Hop W; Schröder FH
J Urol; 1994 Mar; 151(3):646-51. PubMed ID: 7508523
[TBL] [Abstract][Full Text] [Related]
20. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
